Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Book Building
₹ 900
₹ -
-
₹ -
MumbaiNSE
-
-
-
Initial public offering of up to [*] equity shares of face value of Rs. 2 each (Equity Shares) of Shiva Pharmachem Limited (The Company or Issuer) for cash at a price of Rs. [*] per equity share (including a premium of Rs. [*] per equity share) (Offer price) aggregating up to Rs. 900.00 crores (Offer) through an offer for sale of up to [*] equity shares aggregating up to Rs. 383.00 crores Vishal Rakesh Agrawal, up to [*] equity shares aggregating up to Rs. 383.00 crores by Rahul Rakesh Agrawal (collectively, Promoter Selling Shareholders) and up to [*] equity shares aggregating up to Rs. 134.00 crores by Geetganga Investment Private Limited (Promoter Group Selling Shareholder) (the promoter selling shareholders and promoter group selling shareholder, collectively referred to as Selling Shareholders and such offer for sale by the selling shareholders, Offer for Sale). The offer shall constitute [*] % of the post-offer paid-up equity share capital of the company.The price band and the minimum bid lot will be decided by the company.
Listing of the equity shares on the stock exchanges.
Shiva Pharmachem Ltd, C-101 247 Park, L B S Marg, Vikhroli West, Mumbai-400083
Phone - 91-22-49186000
Fax - 91-22-49186060
Website - www.shivapharmachem.com